Halo Labs is revolutionising biopharmaceutical drug product quality by commercialising low volume, high throughput tools to characterise product stability and safety. From developability assessment through quality control, Halo Labs provides unprecedented insights that reduce development time and improve patient safety.
Halo’s management team is a seasoned group of life science professionals who on average have over 20 years of experience delivering solutions to the life science marketplace. Halo’s growth strategy includes disrupting outdated analytical methods as well as addressing the challenges of the fastest growing biopharmaceutical sectors.
Halo’s management team is a seasoned group of life science professionals who on average have over 20 years of experience delivering solutions to the life science marketplace. Halo’s growth strategy includes disrupting outdated analytical methods as well as addressing the challenges of the fastest growing biopharmaceutical sectors.
Aura systems
True low volume, high throughput subvisible particle analysis
Aura™ family systems help you develop stable, pure, and efficacious protein, cell, and gene therapies faster. By combining the sensitivity of BMI with fluorescent detection, Aura systems enable high-throughput particle count, size and identification.
